Beovu

Made by

• Novartis

Active Ingredient

Brolucizumab

Prospectus

Approval date

2020/3/25

Treats

• Age-related macular degeneration

Dosages

• Beovu kit for intravitreal injection 120mg/mL - 142784円／筒